Rheumatoid Arthritis vs. Gout
Title: Rheumatoid Arthritis vs. GoutCategory: Diseases and ConditionsCreated: 3/4/2022 12:00:00 AMLast Editorial Review: 3/4/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 4, 2022 Category: Rheumatology Source Type: news

Rheumatoid Arthritis vs. Ankylosing Spondylitis
Title: Rheumatoid Arthritis vs. Ankylosing SpondylitisCategory: Diseases and ConditionsCreated: 3/4/2022 12:00:00 AMLast Editorial Review: 3/4/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 4, 2022 Category: Rheumatology Source Type: news

Rheumatoid Arthritis vs. Polymyalgia Rheumatica
Title: Rheumatoid Arthritis vs. Polymyalgia RheumaticaCategory: Diseases and ConditionsCreated: 3/4/2022 12:00:00 AMLast Editorial Review: 3/4/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 4, 2022 Category: Rheumatology Source Type: news

Rheumatoid Arthritis vs. Osteoarthritis Hands
Title: Rheumatoid Arthritis vs. Osteoarthritis HandsCategory: Diseases and ConditionsCreated: 3/4/2022 12:00:00 AMLast Editorial Review: 3/4/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 4, 2022 Category: Rheumatology Source Type: news

Arthritis drug could help save Covid patients – study
Rheumatoid arthritis drug baricitinib can reduce risk of death from severe Covid by about a fifthCoronavirus – latest updatesSee all our coronavirus coverageA drug used to treat rheumatoid arthritis could help to save the lives of patients with severe Covid, researchers have found, and they say its benefits can be seen even when it is used on top of other medications.Experts involved in the Randomised Evaluation of Covid-19 Therapy (Recovery) trial say baricitinib, an anti-inflammatory drug taken as a tablet, can reduce the risk of death from severe Covid by about a fifth.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 3, 2022 Category: Science Authors: Nicola Davis Science correspondent Tags: Coronavirus Medical research Health Science Society Source Type: news

Another life-saving Covid drug identified
An anti-inflammatory for rheumatoid arthritis can cut Covid death risk by about a fifth. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 3, 2022 Category: Consumer Health News Source Type: news

Suspend Methotrexate for RA Patients Getting COVID Vax?
(MedPage Today) -- A COVID-19 vaccine's immunogenicity was increased in rheumatoid arthritis patients when they stopped methotrexate temporarily after each dose in a randomized trial, but this benefit came with a cost. Nearly 80% of patients for... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 23, 2022 Category: Rheumatology Source Type: news

WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
WHO ’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countriesSince the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in global treatment guidelinesTwelfth Roche medicine or test to be prequalified Basel, 11 February 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Actemra ®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification. Prequalification is a confi...
Source: Roche Media News - February 22, 2022 Category: Pharmaceuticals Source Type: news

Part B 101: Three charts show the program helps control costs for health care system and enrollees
Medicare Part B covers a wide range of health care services, including physician office visits, hospital outpatient care and medical equipment. It also covers medicines that are usually administered by a physician, like many medicines administered by injections and infusions. Many of the medicines covered by Part B are for serious and complex conditions, such as cancer, rheumatoid arthritis and mental illness, among others. (Source: The Catalyst)
Source: The Catalyst - February 18, 2022 Category: Pharmaceuticals Tags: Medicare Part B Source Type: news

The Omicron Wave Is Receding But the Pandemic Is Far From Over
The U.S. has experienced a brutal winter wave of COVID-19, driven by the highly transmissible Omicron variant. Daily deaths are higher today than they were during the peak of last fall’s Delta wave, and have plateaued at about 2,500 per day. Many hospitals are still under huge strain and are postponing elective surgeries to free up beds for patients with COVID-19. Daily cases have been higher than during the Delta surge, despite multiple eager predictions in the past that we had reached herd immunity and that the pandemic was over. Nevertheless, there are promising signs that we are turning a corner. New daily cases ...
Source: TIME: Health - February 15, 2022 Category: Consumer Health News Authors: Gavin Yamey, Abraar Karan and Ranu Dhillon Tags: Uncategorized COVID-19 Source Type: news

PET predicts treatment response in arthritis patients
PET imaging of immune cells involved in bone and joint damage in rheumatoi...Read more on AuntMinnie.comRelated Reading: Imaging highlights COVID-19's MSK manifestations Skip ultrasound for treatment decisions in rheumatoid arthritis SNMMI: Technetium radiotracer tracks rheumatoid arthritis C-11-based PET tracer could benefit arthritis patients Novel PET tracer could help assess arthritis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 15, 2022 Category: Radiology Source Type: news

WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
WHO ’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countriesSince the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in global treatment guidelinesTwelfth Roche medicine or test to be prequalified Basel, 11 February 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Actemra ®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification. Prequalification is a confi...
Source: Roche Investor Update - February 11, 2022 Category: Pharmaceuticals Source Type: news

AstraZeneca may be best vaccine for people with rheumatoid arthritis, UK Covid Vaccine Research Hub
New data from a team of clinicians in Leeds points to a considerably stronger T-cell response with the AstraZeneca vaccine in a group of people with rheumatoid arthritis, when compared to Pfizer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 10, 2022 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: The four stages of the condition – symptoms of each for you to spot
RHEUMATOID ARTHRITIS affects over 10 million people in the UK. As the condition progresses, there is a varying degree of pain and inflammation associated. (Source: Daily Express - Health)
Source: Daily Express - Health - February 10, 2022 Category: Consumer Health News Source Type: news

Methotrexate-Related AEs Profiled in Early Rheumatoid Arthritis
WEDNESDAY, Feb. 9, 2022 -- Adverse events are common among patients during the first year of treatment with methotrexate for early rheumatoid arthritis, according to a study published online Jan. 25 in Rheumatology. Ahmad A. Sherbini, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2022 Category: Pharmaceuticals Source Type: news